Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score
Conditions
- Heart Failure With Reduced Ejection Fraction
Interventions
- DRUG: Metoprolol Succinate
- DEVICE: Beta-Blocker Polygenic Score
- DEVICE: Illumina Infinium Global Diversity Array with Enhanced Pharmacogenomics (PGx)
Sponsor
University of Michigan
Collaborators